News About: Pharm. Industry
2 of 5 listed pharmas have more than 2 CEOs
2 of 5 listed pharmaceutical companies were known to run their companies with more than 2 CEOs.
With the purpose to responsibly run their company by sharing roles between the largest shareholder and professional mana...
Rebate activities will eventually bring back negative impacts
“In the past, we had to have rebate activities to survive, but now we have to stop them to survive.”
This was a well-known statement among CEOs in the pharmaceutical industry after enforcements of the ‘Rebate Two-Out...
Will trio for ‘2nd Novartis’ rebate investigation kick off?
It was analyzed the prosecution and police, Ministry of Health and Welfare will carry out a rebate investigation that is similar to the one for Novartis Korea announced last August. Although the police are currently k...
Co-promotion of ‘low-profit products’ issued
While co-promotion agreements between foreign and Korean pharmaceutical companies have been made this year, the industry has kept raising complaints that multinational companies only consign low-profit products with l...
Multinational pharmas to make active moves for sales
Multinational pharmaceutical companies have conducted various events to promote their OTC drug sales.
In order to celebrate the 1st anniversary of ‘Actinum EX Plus,’ Takeda Pharmaceuticals Korea recently held the ‘2...
Why Sanofi’s labor union demand reinstatement of two employees violating CP?
Last March, Sanofi-Aventis Korea dismissed its two salespersons, who use corporate expenses without permission, for violation of the Compliance Program(CP).
Later, the company’s labor union has continued a protest to...
Rebate investigation on foreign & Korean pharmas
It was told the police is currently carrying out rebate investigation on about 10 multinational and Korean pharmaceutical companies.
Since some of them are powerful pharmaceutical companies, significant impacts are e...
Multinational pharmas’ OTC drugs averagely have 10% profit rate in pharmacies
Pharmacies’ profits on selling well-known OTC drugs manufactured and distributed by multinational pharmaceutical companies are still observed to stay low.
According to the result of comparing well-known 6 OTC drugs’ ...
Celltrion’s ‘Remsima’ exceeded KRW 1 trillion collective exportsOn the 19th, Celltrion announced the collective exports of its affiliate, Celltrion Healthcare, exceeded KRW 1 trillion. Celltrion Healthcare is an affiliate taking charge in ov...
|
Celltrion’s Remsima presented clinical study result led by Norwegian governmentA result of the long-term clinical trial to research the Remsima’s substitute administration, ‘NOR-SWITCH Study’ was released at the United European Gastroenterology Week(UEGW) ...
|
